MET and hepatocellular carcinoma: Moreover, we found that the C‐MET/STAT3 signaling axis acted as a novel downstream target of PLAGL2 and contributed to the inhibition of PLAGL2‐mediated proliferation and apoptosis induction of SeS2 in HCC in vitro and in vivo.